LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Medicus Pharma Ltd.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERMDCX
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / MDCX COVERAGE

What’s moving Medicus Pharma Ltd. now

Current reporting with the operating signal separated from the noise.

01
Medicus Pharma Ltd: Medicus Pharma Receives FDA "Study May Proceed" Letter for NDA-Enabling Registrational SkinJect Study in Patients with Gorlin Syndrome

Medicus Pharma Ltd: Medicus Pharma Receives FDA "Study May Proceed" Letter for NDA-Enabling Registrational SkinJect Study in Patients with Gorlin Syndrome

The story matters when it changes Medicus Pharma Ltd.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data Approaches Readout and Partnering Readiness Accelerates

Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data Approaches Readout and Partnering Readiness Accelerates

The story matters when it changes Medicus Pharma Ltd.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Medicus Pharma Ltd. Announces $8.0 Million Non-Dilutive Debenture Financing

Medicus Pharma Ltd. Announces $8.0 Million Non-Dilutive Debenture Financing

The story matters when it changes Medicus Pharma Ltd.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Medicus Pharma Ltd. (NASDAQ: MDCX) Positioned for Growth in a $5 Trillion Biotech Market

Medicus Pharma Ltd. (NASDAQ: MDCX) Positioned for Growth in a $5 Trillion Biotech Market

The story matters when it changes Medicus Pharma Ltd.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest MDCX filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-14 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-14 · Period 2025-09-30SEC ↗10-K/AAnnual financial reportFiled 2026-04-29 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-04 · Period 2026-06-03SEC ↗8-KMaterial company eventFiled 2026-05-27 · Period 2026-05-20SEC ↗8-KMaterial company eventFiled 2026-04-24 · Period 2026-04-21SEC ↗6-KOfficial SEC filingFiled 2024-12-26 · Period 2024-12-23SEC ↗6-KOfficial SEC filingFiled 2024-12-12 · Period 2024-12-12SEC ↗
EARNINGS / QUARTERLY TRACKER

Medicus Pharma Ltd., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.